News in brief - November 2014

Other new launches, licence changes and updates relevant to general practice.

Glycopyrronium bromide is an anticholinergic that diminishes the volume and free acidity of gastric secretions.
Glycopyrronium bromide is an anticholinergic that diminishes the volume and free acidity of gastric secretions.
  • Glycopyrronium bromide 1mg and 2mg tablets are now available as an add-on treatment for peptic ulcers.
  • GranuPAS (para-aminosalicylic acid) has been launched for use in combination with other drugs to treat multidrug-resistant TB where other agents cannot be used owing to resistance or intolerance.
  • A new controlled-release misoprostol vaginal delivery system (Mysodelle) has been launched for the induction of labour from 36 weeks' gestation in women with an unfavourable cervix.
  • Dexamethasone 4mg/ml injection has been replaced by dexamethasone 3.8mg/ml solution for injection; as a result, the dilutions, storage conditions, presentation and packaging have changed.
  • Novartis has announced the discontinuation of Tegretol Chewtabs (carbamazepine). Selection of an alternative medication should be a clinical decision based on the individual patient's history.

Follow MIMS on Twitter

Sign up for MIMS bulletins

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more